{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T15:31:23Z","timestamp":1792855883166,"version":"4.5.0"},"reference-count":193,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.jaad.2010.10.043","type":"journal-article","created":{"date-parts":[[2011,8,13]],"date-time":"2011-08-13T15:13:49Z","timestamp":1313248429000},"page":"493-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":151,"title":["Vitiligo: A comprehensive overview"],"prefix":"10.1016","volume":"65","author":[{"given":"Lesley M.","family":"Felsten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Alikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vesna","family":"Petronic-Rosic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaad.2010.10.043_bib1","first-page":"323","article-title":"Clinical predictors of outcome in vitiligo","volume":"68","author":"Dave","year":"2002","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2010.10.043_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1067\/mjd.2002.120576","article-title":"Vitiligo treated with topical corticosteroids: children with head and neck involvement respond well","volume":"46","author":"Cockayne","year":"2002","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib3","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/archderm.1984.01650410073019","article-title":"Vitiligo treated with topical clobetasol propionate","volume":"120","author":"Kumari","year":"1984","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib4","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1111\/j.1346-8138.1991.tb03092.x","article-title":"Treatment of vitiligo with oral 5-methoxypsoralen","volume":"18","author":"Hann","year":"1991","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib5","first-page":"170","article-title":"Treatment of vitiligo with oral methoxsalen and UVA","volume":"1","author":"Lassus","year":"1984","journal-title":"Photodermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jaad.2004.05.036","article-title":"Tacrolimus ointment promotes repigmentation of vitiligo in children: a review of 57 cases","volume":"51","author":"Silverberg","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib7","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1111\/j.1468-3083.2007.02278.x","article-title":"Critical evaluation of the variants influencing the clinical response of vitiligo: study of 60 cases treated with ultraviolet B narrow-band phototherapy","volume":"21","author":"Brazzelli","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.1711700209","article-title":"An immunohistological study of cutaneous lymphocytes in vitiligo","volume":"170","author":"Badri","year":"1993","journal-title":"J Pathol"},{"key":"10.1016\/j.jaad.2010.10.043_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/labinvest.3780138","article-title":"Local immune response in skin of generalized vitiligo patients. Destruction of melanocytes is associated with the prominent presence of CLA+ T cells at the perilesional site","volume":"80","author":"van den Wijngaard","year":"2000","journal-title":"Lab Invest"},{"key":"10.1016\/j.jaad.2010.10.043_bib10","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0923-1811(93)90039-R","article-title":"The change of melanocyte cytotoxicity after systemic steroid treatment in vitiligo patients","volume":"6","author":"Hann","year":"1993","journal-title":"J Dermatol Sci"},{"issue":"suppl 12","key":"10.1016\/j.jaad.2010.10.043_bib11","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2133.1976.tb02268.x","article-title":"The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies","volume":"94","author":"Bleehen","year":"1976","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/j.1365-2133.1974.tb13086.x","article-title":"Treatment of vitiligo with 0-1 per cent betamethasone 17-valerate in isopropyl alcohol\u2014a double-blind trial","volume":"91","author":"Kandil","year":"1974","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib13","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.jaad.2006.08.017","article-title":"High-potency steroid use in children with vitiligo: a retrospective study","volume":"56","author":"Kwinter","year":"2007","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib14","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1001\/archderm.139.5.581","article-title":"A double-blind randomized trial of 0.1% tacrolimus vs 0.05% clobetasol for the treatment of childhood vitiligo","volume":"139","author":"Lepe","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib15","first-page":"88","article-title":"Topical 0.05% clobetasol propionate versus 1% pimecrolimus ointment in vitiligo","volume":"15","author":"Coskun","year":"2005","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib16","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/archderm.135.9.1061","article-title":"Left-right comparison study of the combination of fluticasone propionate and UV-A vs. either fluticasone propionate or UV-A alone for the long-term treatment of vitiligo","volume":"135","author":"Westerhof","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1046\/j.1365-4362.2000.00006.x","article-title":"Use of high-dose methylprednisolone pulse therapy in patients with progressive and stable vitiligo","volume":"39","author":"Seiter","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib18","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1067\/mjd.2001.113475","article-title":"Oral dexamethasone pulse treatment for vitiligo","volume":"44","author":"Radakovic-Fijan","year":"2001","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib19","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1046\/j.1365-4362.1999.00623.x","article-title":"The efficacy of low-dose oral corticosteroids in the treatment of vitiligo patients","volume":"38","author":"Kim","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib20","doi-asserted-by":"crossref","first-page":"357","DOI":"10.4103\/0378-6323.42905","article-title":"An open labeled, comparative clinical study on efficacy and tolerability of oral minipulse of steroid (OMP) alone, OMP with PUVA and broad \/ narrow band UVB phototherapy in progressive vitiligo","volume":"74","author":"Rath","year":"2008","journal-title":"Indian J Dermatol Venereol Leprol"},{"issue":"5 suppl","key":"10.1016\/j.jaad.2010.10.043_bib21","doi-asserted-by":"crossref","first-page":"S166","DOI":"10.1590\/S0021-75572006000700006","article-title":"Calcineurin inhibitors in the treatment of allergic dermatitis","volume":"82","author":"Castro","year":"2006","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/j.jaad.2010.10.043_bib22","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jaad.2003.12.031","article-title":"Topical tacrolimus therapy for vitiligo: therapeutic responses and skin messenger RNA expression of proinflammatory cytokines","volume":"51","author":"Grimes","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib23","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1365-2133.2005.06739.x","article-title":"FK506 promotes melanocyte and melanoblast growth and creates a favourable milieu for cell migration via keratinocytes: possible mechanisms of how tacrolimus ointment induces repigmentation in patients with vitiligo","volume":"153","author":"Lan","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib24","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-4632.2009.03852.x","article-title":"Efficacy and safety of tarcrolimus cream 0.1% in the treatment of vitiligo","volume":"48","author":"Xu","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib25","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2340\/00015555-0464","article-title":"Occlusive treatment enhances efficacy of tacrolimus 0.1% ointment in adult patients with vitiligo: results of a placebo-controlled 12-month prospective study","volume":"88","author":"Hartmann","year":"2008","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib26","first-page":"158","article-title":"Tacrolimus ointment 0.1% produces repigmentation in patients with vitiligo: results of a prospective patient series","volume":"71","author":"Tanghetti","year":"2003","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2010.10.043_bib27","first-page":"517","article-title":"Retrospective analysis of pimecrolimus cream 1% for treatment of facial vitiligo","volume":"6","author":"Mayoral","year":"2007","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib28","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1159\/000099592","article-title":"Pimecrolimus cream in repigmentation of vitiligo","volume":"214","author":"Seirafi","year":"2007","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib29","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1610-0387.2007.06455.x","article-title":"Repigmentation of pretibial vitiligo with calcineurin inhibitors under occlusion","volume":"6","author":"Hartmann","year":"2008","journal-title":"J Deutschen Dermatologischen Gesellschaft"},{"key":"10.1016\/j.jaad.2010.10.043_bib30","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1346-8138.2008.00511.x","article-title":"Topical immunomodulators are effective for treatment of vitiligo","volume":"35","author":"Choi","year":"2008","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib31","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1001\/archderm.142.7.927","article-title":"A randomized, placebo-controlled, double-blind trial comparing narrowband UV-B plus 0.1% tacrolimus ointment with narrowband UV-B plus placebo in the treatment of generalized vitiligo","volume":"142","author":"Mehrabi","year":"2006","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib32","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/j.1468-3083.2006.02101.x","article-title":"Narrow-band UVB phototherapy combined with tacrolimus ointment in vitiligo: a review of 110 patients","volume":"21","author":"Fai","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib33","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1080\/09546630802155057","article-title":"The efficacy of pimecrolimus 1% cream plus narrow-band ultraviolet B in the treatment of vitiligo: a double-blind, placebo-controlled clinical trial","volume":"20","author":"Esfandiarpour","year":"2009","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.10.043_bib34","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1001\/archderm.140.9.1065","article-title":"Topical tacrolimus and the 308-nm excimer laser: a synergistic combination for the treatment of vitiligo","volume":"140","author":"Passeron","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1751-7125.2008.07558.x","article-title":"Tacrolimus-induced hyperpigmentation in a patch of vitiligo","volume":"7","author":"De","year":"2008","journal-title":"Skinmed"},{"key":"10.1016\/j.jaad.2010.10.043_bib36","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1001\/archderm.143.9.1223","article-title":"Focal acne during topical tacrolimus therapy for vitiligo","volume":"143","author":"Bakos","year":"2007","journal-title":"Arch Dermatol"},{"issue":"2 pt 1","key":"10.1016\/j.jaad.2010.10.043_bib37","first-page":"130","article-title":"Combined excimer laser and topical tacrolimus for the treatment of vitiligo: a pilot study","volume":"30","author":"Kawalek","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib38","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.clindermatol.2009.04.001","article-title":"Malignancy concerns of topical calcineurin inhibitors for atopic dermatitis: facts and controversies","volume":"28","author":"Thaci","year":"2010","journal-title":"Clin Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib39","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1525-1470.2010.01223.x","article-title":"The safety and efficacy of tacrolimus ointment in pediatric patients with atopic dermatitis","volume":"27","author":"McCollum","year":"2010","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib40","unstructured":"US Food and Drug Administration Web site. Available from: www.fda.gov. Accessed June 1, 2011."},{"key":"10.1016\/j.jaad.2010.10.043_bib41","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s11095-007-9388-z","article-title":"Calcipotriol affects keratinocyte proliferation by decreasing expression of early growth response-1 and polo-like kinase-2","volume":"25","author":"Kristl","year":"2008","journal-title":"Pharm Res"},{"key":"10.1016\/j.jaad.2010.10.043_bib42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.humimm.2009.01.016","article-title":"Dendritic cell tolerogenicity: a key mechanism in immunomodulation by vitamin D receptor agonists","volume":"70","author":"Adorini","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jaad.2010.10.043_bib43","doi-asserted-by":"crossref","first-page":"345","DOI":"10.2174\/138945008783954970","article-title":"Cellular and molecular mechanisms involved in the action of vitamin D analogs targeting vitiligo depigmentation","volume":"9","author":"Birlea","year":"2008","journal-title":"Curr Drug Targets"},{"key":"10.1016\/j.jaad.2010.10.043_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1046\/j.1525-1470.1999.00083.x","article-title":"Calcipotriol in vitiligo: a preliminary study","volume":"16","author":"Parsad","year":"1999","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib45","first-page":"11","article-title":"Calcipotriol in the treatment of childhood vitiligo","volume":"24","author":"Gargoom","year":"2004","journal-title":"Int J Clin Pharmacol Res"},{"key":"10.1016\/j.jaad.2010.10.043_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1111\/j.1468-3083.2006.01420.x","article-title":"Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo","volume":"20","author":"Kumaran","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib47","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.0736-8046.2004.21418.x","article-title":"Calcipotriene and corticosteroid combination therapy for vitiligo","volume":"21","author":"Travis","year":"2004","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib48","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1346-8138.2006.00079.x","article-title":"Narrow-band ultraviolet B as monotherapy and in combination with topical calcipotriol in the treatment of vitiligo","volume":"33","author":"Arca","year":"2006","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib49","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1365-4632.2004.02154.x","article-title":"Narrow-band UVB311 nm vs. broad-band UVB therapy in combination with topical calcipotriol vs. placebo in vitiligo","volume":"44","author":"Hartmann","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib50","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/j.1600-0781.2005.00139.x","article-title":"No additional effect of topical calcipotriol on narrow-band UVB phototherapy in patients with generalized vitiligo","volume":"21","author":"Ada","year":"2005","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib51","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1468-3083.2006.01546.x","article-title":"Combination of narrow band UVB and topical calcipotriol for the treatment of vitiligo","volume":"20","author":"Goktas","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib52","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1046\/j.1365-2133.2001.04286.x","article-title":"Is the efficacy of psoralen plus ultraviolet A therapy for vitiligo enhanced by concurrent topical calcipotriol? A placebo-controlled double-blind study","volume":"145","author":"Ermis","year":"2001","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib53","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1111\/j.1365-2133.2006.07584.x","article-title":"Effects of psoralen plus ultraviolet A irradiation on cultured epidermal cells in\u00a0vitro and patients with vitiligo in\u00a0vivo","volume":"156","author":"Wu","year":"2007","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib54","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1001\/archderm.1997.03890480050007","article-title":"Oral psoralen with UV-A therapy releases circulating growth factor(s) that stimulates cell proliferation","volume":"133","author":"Abdel-Naser","year":"1997","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib55","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1562\/2005-02-15-IR-441","article-title":"UVR, vitamin D and three autoimmune diseases\u2014multiple sclerosis, type 1 diabetes, rheumatoid arthritis","volume":"81","author":"Ponsonby","year":"2005","journal-title":"Photochem Photobiol"},{"key":"10.1016\/j.jaad.2010.10.043_bib56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.1979.tb15285.x","article-title":"PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study","volume":"101","author":"Ortonne","year":"1979","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib57","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1111\/1523-1747.ep12499936","article-title":"Comparison of the effect of 8-methoxypsoralen (8-MOP) plus UVA (PUVA) on human melanocytes in vitiligo vulgaris and in\u00a0vitro","volume":"98","author":"Kao","year":"1992","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib58","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0190-9622(03)00786-2","article-title":"Clinical study of repigmentation patterns with different treatment modalities and their correlation with speed and stability of repigmentation in 352 vitiliginous patches","volume":"50","author":"Parsad","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib59","unstructured":"[Homepage on the Internet]. Available from: http:\/\/www.clinicalpharmacology.com."},{"key":"10.1016\/j.jaad.2010.10.043_bib60","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1600-0781.2006.00229.x","article-title":"Ultraviolet A in vitiligo","volume":"22","author":"El-Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib61","first-page":"292","article-title":"Immunohistochemical study before and after narrow band (311 nm) UVB treatment in vitiligo","volume":"18","author":"De Francesco","year":"2008","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib62","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1111\/j.1365-4632.2009.03928.x","article-title":"Therapeutic evaluation of UVB-targeted phototherapy in vitiligo that affects less than 10% of the body surface area","volume":"48","author":"Welsh","year":"2009","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib63","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1365-2230.2005.01837.x","article-title":"Narrow-band UVB for the treatment of generalized vitiligo in children","volume":"30","author":"Kanwar","year":"2005","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib64","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/j.1365-4632.2004.02329.x","article-title":"Narrow-band UVB for the treatment of vitiligo: an emerging effective and well-tolerated therapy","volume":"44","author":"Kanwar","year":"2005","journal-title":"Int J Dermatol"},{"issue":"2 pt 1","key":"10.1016\/j.jaad.2010.10.043_bib65","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/S0190-9622(00)90133-6","article-title":"Treatment of generalized vitiligo in children with narrow-band (TL-01) UVB radiation therapy","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib66","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1111\/j.1346-8138.2005.tb00847.x","article-title":"Narrow-band UVB treatment of vitiligo in Chinese","volume":"32","author":"Chen","year":"2005","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib67","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1600-0781.2006.00189.x","article-title":"Narrow band ultraviolet B 311 nm in the treatment of vitiligo: two right-left comparison studies","volume":"22","author":"El Mofty","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib68","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1034\/j.1600-0781.2001.170403.x","article-title":"PUVA and PUVB in vitiligo\u2014are they equally effective?","volume":"17","author":"Mofty","year":"2001","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib69","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1111\/j.1468-3083.2007.02283.x","article-title":"Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study","volume":"21","author":"Bhatnagar","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib70","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1468-3083.2006.01413.x","article-title":"Psoralen-ultraviolet A vs. narrow-band ultraviolet B phototherapy for the treatment of vitiligo","volume":"20","author":"Parsad","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib71","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1001\/archderm.1971.04000170009002","article-title":"Vitiligo treated by psoralens. A long-term follow-up study of the permanency of repigmentation","volume":"103","author":"Kenney","year":"1971","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib72","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2340\/0001555572305306","article-title":"PUVA treatment of vitiligo: a retrospective study of 59 patients","volume":"72","author":"Wildfang","year":"1992","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib73","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1111\/j.1365-2230.2004.01462.x","article-title":"Treatment of vitiligo with local khellin and UVA: comparison with systemic PUVA","volume":"29","author":"Valkova","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib74","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1111\/j.1365-2230.2004.01536.x","article-title":"Psoralen plus ultraviolet A irradiation-induced lentigines arising in vitiligo: involvement of vitiliginous and normal appearing skin","volume":"29","author":"Abdel Naser","year":"2004","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.burns.2006.07.005","article-title":"Burns caused by accidental overdose of photochemotherapy (PUVA)","volume":"33","author":"Herr","year":"2007","journal-title":"Burns"},{"key":"10.1016\/j.jaad.2010.10.043_bib76","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1159\/000018215","article-title":"Carcinogenic risk of bath PUVA in comparison to oral PUVA therapy","volume":"199","author":"Shephard","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib77","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1046\/j.1468-3083.2003.00815.x","article-title":"Squamous cell carcinoma in vitiligo lesion after long-term PUVA therapy","volume":"17","author":"Park","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib78","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaad.2008.12.031","article-title":"Treatments for psoriasis and the risk of malignancy","volume":"60","author":"Patel","year":"2009","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib79","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2165\/00002018-199920040-00001","article-title":"Risk of melanoma with psoralen\/ultraviolet A therapy for psoriasis. Do the known risks now outweigh the benefits?","volume":"20","author":"Lindelof","year":"1999","journal-title":"Drug Saf"},{"key":"10.1016\/j.jaad.2010.10.043_bib80","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1365-2133.2008.08776.x","article-title":"Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy","volume":"159","author":"Hearn","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib81","series-title":"Dermatological phototherapy and photodiagnostic methods","first-page":"151","article-title":"Phototherapeutic options for vitiligo","author":"Ortel","year":"2009"},{"key":"10.1016\/j.jaad.2010.10.043_bib82","first-page":"522","article-title":"The excimer lasers","volume":"3","author":"Spencer","year":"2004","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib83","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1089\/pho.2007.2086","article-title":"Optimal frequency of treatment with the 308-nm excimer laser for vitiligo on the face and neck","volume":"25","author":"Shen","year":"2007","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib84","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1046\/j.1468-3083.2003.00818.x","article-title":"Monochromatic excimer light 308 nm in the treatment of vitiligo: a pilot study","volume":"17","author":"Leone","year":"2003","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib85","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1002\/lsm.20057","article-title":"Treatment of vitiligo by 308-nm excimer laser: an evaluation of variables affecting treatment response","volume":"35","author":"Ostovari","year":"2004","journal-title":"Lasers Surg Med"},{"key":"10.1016\/j.jaad.2010.10.043_bib86","first-page":"983","article-title":"The use of the 308-nm excimer laser for the treatment of vitiligo","volume":"30","author":"Hadi","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib87","first-page":"13","article-title":"Using a 308-nm excimer laser to treat vitiligo in Asians","volume":"18","author":"Al-Otaibi","year":"2009","journal-title":"Acta Dermatovenerol Alp Panonica Adriat"},{"key":"10.1016\/j.jaad.2010.10.043_bib88","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1468-3083.2006.01547.x","article-title":"The efficacy of excimer laser (308 nm) for vitiligo at different body sites","volume":"20","author":"Hofer","year":"2006","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib89","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2133.2004.06321.x","article-title":"Optimal weekly frequency of 308-nm excimer laser treatment in vitiligo patients","volume":"152","author":"Hofer","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib90","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1089\/pho.2006.24.354","article-title":"Treatment of vitiligo using the 308-nm excimer laser","volume":"24","author":"Hadi","year":"2006","journal-title":"Photomed Laser Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib91","doi-asserted-by":"crossref","first-page":"273","DOI":"10.3346\/jkms.2005.20.2.273","article-title":"Short-term effects of 308-nm xenon-chloride excimer laser and narrow-band ultraviolet B in the treatment of vitiligo: a comparative study","volume":"20","author":"Hong","year":"2005","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.jaad.2010.10.043_bib92","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1111\/j.1468-3083.2007.02151.x","article-title":"Comparison between 308-nm monochromatic excimer light and narrowband UVB phototherapy (311-313 nm) in the treatment of vitiligo\u2014a multicentre controlled study","volume":"21","author":"Casacci","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib93","first-page":"1186","article-title":"Randomized controlled trial comparing the effectiveness of 308-nm excimer laser alone or in combination with topical hydrocortisone 17-butyrate cream in the treatment of vitiligo of the face and neck","volume":"159","author":"Sassi","year":"2008","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib94","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1468-3083.2006.02016.x","article-title":"Combination of 308-nm xenon chloride excimer laser and topical calcipotriol in vitiligo","volume":"21","author":"Goldinger","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib95","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/j.1600-0781.2006.00250.x","article-title":"Topical tacalcitol and 308-nm monochromatic excimer light: a synergistic combination for the treatment of vitiligo","volume":"22","author":"Lu-yan","year":"2006","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib96","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1529-8019.2009.01252.x","article-title":"Monochromatic excimer light 308 nm in monotherapy and combined with topical khellin 4% in the treatment of vitiligo: a controlled study","volume":"22","author":"Saraceno","year":"2009","journal-title":"Dermatol Ther"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.10.043_bib97","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1111\/j.1529-8019.2008.00198.x","article-title":"Targeted and combination treatments for vitiligo. Comparative evaluation of different current modalities in 458 subjects","volume":"21","author":"Lotti","year":"2008","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2010.10.043_bib98","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/S1607-551X(08)70115-3","article-title":"Low-energy helium-neon laser therapy induces repigmentation and improves the abnormalities of cutaneous microcirculation in segmental-type vitiligo lesions","volume":"24","author":"Wu","year":"2008","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/j.jaad.2010.10.043_bib99","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1038\/sj.jid.5700372","article-title":"Low-energy helium-neon laser induces locomotion of the immature melanoblasts and promotes melanogenesis of the more differentiated melanoblasts: recapitulation of vitiligo repigmentation in\u00a0vitro","volume":"126","author":"Lan","year":"2006","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib100","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1046\/j.1523-1747.2003.12011.x","article-title":"Helium-neon laser irradiation stimulates migration and proliferation in melanocytes and induces repigmentation in segmental-type vitiligo","volume":"120","author":"Yu","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib101","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1365-2230.2007.02627.x","article-title":"Efficacy of local psoralen ultraviolet A treatments in psoriasis, vitiligo and eczema","volume":"33","author":"Adisen","year":"2008","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib102","first-page":"357","article-title":"Localized vitiligo successfully treated with cream-psoralen + ultraviolet A","volume":"15","author":"Kreuter","year":"2001","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib103","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1046\/j.1365-2133.2003.05577.x","article-title":"KUVA (khellin plus ultraviolet A) stimulates proliferation and melanogenesis in normal human melanocytes and melanoma cells in\u00a0vitro","volume":"149","author":"Carlie","year":"2003","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib104","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1159\/000247517","article-title":"Photochemotherapy with topical khellin and sunlight in vitiligo","volume":"184","author":"Orecchia","year":"1992","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib105","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1159\/000249932","article-title":"An approach to the treatment of vitiligo by khellin","volume":"165","author":"Abdel-Fattah","year":"1982","journal-title":"Dermatologica"},{"key":"10.1016\/j.jaad.2010.10.043_bib106","first-page":"225","article-title":"Long-term results in the treatment of vitiligo with oral khellin plus UVA","volume":"11","author":"Hofer","year":"2001","journal-title":"Eur J Dermatol"},{"issue":"4 pt 1","key":"10.1016\/j.jaad.2010.10.043_bib107","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/S0190-9622(88)70092-4","article-title":"Treatment of vitiligo with khellin and ultraviolet A","volume":"18","author":"Ortel","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib108","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2340\/000155559575232233","article-title":"Provocation of porphyria cutanea tarda by KUVA-therapy of vitiligo","volume":"75","author":"Jansen","year":"1995","journal-title":"Acta Derm Venereol"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.10.043_bib109","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/j.ymgme.2005.07.023","article-title":"Decreased phenylalanine uptake and turnover in patients with vitiligo","volume":"86","author":"Schallreuter","year":"2005","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.jaad.2010.10.043_bib110","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2340\/0001555566259262","article-title":"Langerhans\u2019 cell population studies with OKT6 and HLA-DR monoclonal antibodies in vitiligo patients treated with oral phenylalanine loading and UVA irradiation","volume":"66","author":"Westerhof","year":"1986","journal-title":"Acta Derm Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib111","first-page":"149","article-title":"Oral phenylalanine loading and sunlight as source of UVA irradiation in vitiligo on the caribbean island of curacao NA","volume":"89","author":"Kuiters","year":"1986","journal-title":"J Trop Med Hyg"},{"key":"10.1016\/j.jaad.2010.10.043_bib112","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1111\/j.1525-1470.1989.tb00921.x","article-title":"Phenylalanine plus ultraviolet light: preliminary report of a promising treatment for childhood vitiligo","volume":"6","author":"Schulpis","year":"1989","journal-title":"Pediatr Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib113","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000247142","article-title":"L-phenylalanine and UVA irradiation in the treatment of vitiligo","volume":"188","author":"Siddiqui","year":"1994","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib114","first-page":"519","article-title":"Repigmentation treatment of vitiligo with L-phenylalanine and UVA irradiation","volume":"62","author":"Thiele","year":"1987","journal-title":"Z Hautkr"},{"key":"10.1016\/j.jaad.2010.10.043_bib115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1001\/archderm.135.2.216","article-title":"Treatment of vitiligo with oral and topical phenylalanine: 6 years of experience","volume":"135","author":"Camacho","year":"1999","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib116","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-4362.1989.tb04613.x","article-title":"Vitiligo therapy with oral and topical phenylalanine with UVA exposure","volume":"28","author":"Antoniou","year":"1989","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib117","first-page":"127","article-title":"Oral and topical L-phenylalanine, clobetasol propionate, and UVA\/sunlight\u2014a new study for the treatment of vitiligo","volume":"1","author":"Camacho","year":"2002","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib118","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1007\/s001050050104","article-title":"Vitiligo therapy with phenylalanine\/UV A. Catamnestic studies after five years","volume":"45","author":"Greiner","year":"1994","journal-title":"Hautarzt"},{"key":"10.1016\/j.jaad.2010.10.043_bib119","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/j.1365-2133.2009.09288.x","article-title":"Decreased methionine sulphoxide reductase A expression renders melanocytes more sensitive to oxidative stress: a possible cause for melanocyte loss in vitiligo","volume":"161","author":"Zhou","year":"2009","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/j.1365-2230.2007.02514.x","article-title":"Antioxidants and narrow band-UVB in the treatment of vitiligo: a double-blind placebo controlled trial","volume":"32","author":"Dell\u2019Anna","year":"2007","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib121","first-page":"21","article-title":"Evaluation of an antioxidant and mitochondria-stimulating cream formula on the skin of patients with stable common vitiligo","volume":"48","author":"Rojas-Urdaneta","year":"2007","journal-title":"Invest Clin"},{"key":"10.1016\/j.jaad.2010.10.043_bib122","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1046\/j.1365-2230.2003.01207.x","article-title":"Effectiveness of oral ginkgo biloba in treating limited, slowly spreading vitiligo","volume":"28","author":"Parsad","year":"2003","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib123","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/0091270009335769","article-title":"Response of vitiligo to narrowband ultraviolet B and oral antioxidants","volume":"49","author":"Elgoweini","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.jaad.2010.10.043_bib124","first-page":"24","article-title":"The effects of vitamin E on the skin lipid peroxidation and the clinical improvement in vitiligo patients treated with PUVA","volume":"12","author":"Akyol","year":"2002","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib125","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1159\/000246690","article-title":"Treatment of vitiligo with a topical application of pseudocatalase and calcium in combination with short-term UVB exposure: a case study on 33 patients","volume":"190","author":"Schallreuter","year":"1995","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib126","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1684\/ejd.2009.0699","article-title":"Comparison of the efficacy of narrow band ultraviolet B and narrow band ultraviolet B plus topical catalase-superoxide dismutase treatment in vitiligo patients","volume":"19","author":"Yuksel","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib127","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1365-2230.2002.01142.x","article-title":"Topical pseudocatalase mousse and narrowband UVB phototherapy is not effective for vitiligo: an open, single-centre study","volume":"27","author":"Patel","year":"2002","journal-title":"Clin Exp Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib128","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-4362.2002.01463.x","article-title":"Rapid initiation of repigmentation in vitiligo with dead sea climatotherapy in combination with pseudocatalase (PC-KUS)","volume":"41","author":"Schallreuter","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib129","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1468-3083.2008.02839.x","article-title":"A double-blind, randomized trial of 0.05% betamethasone vs. topical catalase\/dismutase superoxide in vitiligo","volume":"22","author":"Sanclemente","year":"2008","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib130","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1600-0781.1997.tb00108.x","article-title":"Topical or oral administration with an extract of polypodium leucotomos prevents acute sunburn and psoralen-induced phototoxic reactions as well as depletion of Langerhans cells in human skin","volume":"13","author":"Gonzalez","year":"1997","journal-title":"Photodermatol Photoimmunol Photomed"},{"key":"10.1016\/j.jaad.2010.10.043_bib131","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/j.1468-3083.2006.02132.x","article-title":"Treatment of vitiligo vulgaris with narrow-band UVB and oral polypodium leucotomos extract: a randomized double-blind placebo-controlled study","volume":"21","author":"Middelkamp-Hup","year":"2007","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib132","first-page":"48","article-title":"Cuprum sulfate and vitix in the treatment of vitiligo in children","volume":"121","author":"Tsiskarishvili","year":"2005","journal-title":"Georgian Med News"},{"key":"10.1016\/j.jaad.2010.10.043_bib133","first-page":"219","article-title":"Treatment of vitiligo with autologous epidermal transplantation using the roofs of suction blisters","volume":"4","author":"Tang","year":"1998","journal-title":"Hong Kong Med J"},{"key":"10.1016\/j.jaad.2010.10.043_bib134","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1001\/archderm.1988.01670110016003","article-title":"Epidermal grafting using the tops of suction blisters in the treatment of vitiligo","volume":"124","author":"Koga","year":"1988","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib135","doi-asserted-by":"crossref","first-page":"321","DOI":"10.4103\/0378-6323.16781","article-title":"Reliable site for suction blister induction and harvesting","volume":"71","author":"Laxmisha","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2010.10.043_bib136","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1046\/j.1365-4362.2000.00989.x","article-title":"Suction blister grafting for stable vitiligo using pulsed erbium: YAG laser ablation for recipient site","volume":"39","author":"Sachdev","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib137","first-page":"679","article-title":"Clinical management with efalizumab of a patient with psoriasis and comorbid vitiligo","volume":"7","author":"Fernandez-Obregon","year":"2008","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib138","first-page":"855","article-title":"Epidermal grafting after chemical epilation in the treatment of vitiligo","volume":"27","author":"Kim","year":"2001","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib139","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1046\/j.1365-4362.1999.00702.x","article-title":"Modified technique of suction blistering for epidermal grafting in vitiligo","volume":"38","author":"Gupta","year":"1999","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib140","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0190-9622(90)70013-8","article-title":"Therapeutic success of epidermal grafting in generalized vitiligo is limited by the koebner phenomenon","volume":"22","author":"Hatchome","year":"1990","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib141","first-page":"824","article-title":"Repigmentation of vitiligo with autologous blister-induced epidermal grafts","volume":"28","author":"Lim","year":"1999","journal-title":"Ann Acad Med Singapore"},{"key":"10.1016\/j.jaad.2010.10.043_bib142","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1473-2165.2007.00307.x","article-title":"Epithelial grafting for vitiligo requires ultraviolet A phototherapy to increase success rate","volume":"6","author":"Awad","year":"2007","journal-title":"J Cosmet Derm"},{"key":"10.1016\/j.jaad.2010.10.043_bib143","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1097\/01.PRS.0000047023.07901.0A","article-title":"Carbon dioxide laser resurfacing and thin skin grafting in the treatment of \u201cstable and recalcitrant\u201d vitiligo","volume":"111","author":"Acikel","year":"2003","journal-title":"Plast Reconstr Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib144","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1524-4725.1995.tb00176.x","article-title":"Vitiligo: repigmentation with dermabrasion and thin split-thickness skin graft","volume":"21","author":"Agrawal","year":"1995","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib145","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1046\/j.1365-4362.2002.01391.x","article-title":"Comparison of two surgical approaches for treating vitiligo: a preliminary study","volume":"41","author":"Ozdemir","year":"2002","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib146","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1097\/00042728-200504000-00010","article-title":"Comparison of minipunch grafting versus split-skin grafting in chronic stable vitiligo","volume":"31","author":"Khandpur","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib147","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/j.1755-148X.2008.00528.x","article-title":"Update on skin repigmentation therapies in vitiligo","volume":"22","author":"Falabella","year":"2009","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.jaad.2010.10.043_bib148","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/0190-9622(95)90292-9","article-title":"Repigmentation in vitiligo vulgaris by autologous minigrafting: results in nineteen patients","volume":"33","author":"Boersma","year":"1995","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib149","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000018089","article-title":"Treatment of stable and recalcitrant vitiligo by autologous miniature punch grafting: a prospective study of 1,000 patients","volume":"198","author":"Malakar","year":"1999","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib150","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1046\/j.1365-4362.2000.00097.x","article-title":"Dermatologic surgery: pulsed erbium: YAG laser-assisted autologous epidermal punch grafting in vitiligo","volume":"39","author":"Sachdev","year":"2000","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib151","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1365-4632.2005.02697.x","article-title":"Repigmentation of vitiligo with punch grafting and narrow-band UV-B (311 nm)\u2014a prospective study","volume":"45","author":"Lahiri","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib152","first-page":"49","article-title":"A comparative study of punch grafting followed by topical corticosteroid versus punch grafting followed by PUVA therapy in stable vitiligo","volume":"30","author":"Barman","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib153","doi-asserted-by":"crossref","first-page":"393","DOI":"10.4103\/0378-6323.18942","article-title":"A study of autologous melanocyte transfer in treatment of stable vitiligo","volume":"71","author":"Pandya","year":"2005","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"10.1016\/j.jaad.2010.10.043_bib154","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/archderm.140.10.1203","article-title":"Double-blind placebo-controlled study of autologous transplanted epidermal cell suspensions for repigmenting vitiligo","volume":"140","author":"van Geel","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib155","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1111\/j.1365-4632.2005.02226.x","article-title":"Long-term follow-up study of 142 patients with vitiligo vulgaris treated by autologous, non-cultured melanocyte-keratinocyte cell transplantation","volume":"44","author":"Mulekar","year":"2005","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib156","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1001\/archderm.140.10.1211","article-title":"Long-term follow-up study of segmental and focal vitiligo treated by autologous, noncultured melanocyte-keratinocyte cell transplantation","volume":"140","author":"Mulekar","year":"2004","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib157","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1346-8138.2000.tb02201.x","article-title":"Transplant of cultured autologous pure melanocytes after laser-abrasion for the treatment of segmental vitiligo","volume":"27","author":"Chen","year":"2000","journal-title":"J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib158","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1097\/00042728-200502000-00006","article-title":"Autologous epidermal cultures and narrow-band ultraviolet B in the surgical treatment of vitiligo","volume":"31","author":"Pianigiani","year":"2005","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib159","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1159\/000092833","article-title":"Subjective and objective evaluation of noncultured epidermal cellular grafting for repigmenting vitiligo","volume":"213","author":"van Geel","year":"2006","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib160","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1046\/j.1524-4725.1999.07349.x","article-title":"Silicone gel sheet dressings for prevention of post-minigraft cobblestoning in vitiligo","volume":"25","author":"Agarwal","year":"1999","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib161","first-page":"641","article-title":"Acquired leukomelanoderma caused by topical depigmenting agents","volume":"109","author":"Grojean","year":"1982","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/j.jaad.2010.10.043_bib162","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1038\/jid.2009.214","article-title":"Monobenzyl ether of hydroquinone and 4-tertiary butyl phenol activate markedly different physiological responses in melanocytes: relevance to skin depigmentation","volume":"130","author":"Hariharan","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib163","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/j.1365-2133.1977.tb14275.x","article-title":"Monobenzylether of hydroquinone. A retrospective study of treatment of 18 vitiligo patients and a review of the literature","volume":"97","author":"Mosher","year":"1977","journal-title":"Br J Dermatol"},{"issue":"5 pt 1","key":"10.1016\/j.jaad.2010.10.043_bib164","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1067\/mjd.2000.103813","article-title":"Depigmentation therapy in vitiligo universalis with topical 4-methoxyphenol and the Q-switched ruby laser","volume":"42","author":"Njoo","year":"2000","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib165","first-page":"1043","article-title":"Use of the Q-switched 755-nm alexandrite laser to treat recalcitrant pigment after depigmentation therapy for vitiligo","volume":"30","author":"Rao","year":"2004","journal-title":"Dermatol Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib166","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1046\/j.1365-4362.1997.00144.x","article-title":"Laser treatment for further depigmentation in vitiligo","volume":"36","author":"Thissen","year":"1997","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib167","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1001\/archderm.1985.01660090055013","article-title":"Dermatitis produced by applications of monobenzone in patients with active vitiligo","volume":"121","author":"Nordlund","year":"1985","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib168","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1001\/archopht.1983.01040010066010","article-title":"Corneal and conjunctival effects of monobenzone in patients with vitiligo","volume":"101","author":"Hedges","year":"1983","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jaad.2010.10.043_bib169","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000084751","article-title":"Quality of life and stigmatization profile in a cohort of vitiligo patients and effect of the use of camouflage","volume":"210","author":"Ongenae","year":"2005","journal-title":"Dermatology"},{"issue":"suppl 1","key":"10.1016\/j.jaad.2010.10.043_bib170","first-page":"S19","article-title":"Vitiligo: an under-estimated problem","volume":"15","author":"Agarwal","year":"1998","journal-title":"Fam Pract"},{"key":"10.1016\/j.jaad.2010.10.043_bib171","first-page":"110","article-title":"Corrective camouflage in pediatric dermatology","volume":"79","author":"Tedeschi","year":"2007","journal-title":"Cutis"},{"key":"10.1016\/j.jaad.2010.10.043_bib172","first-page":"23","article-title":"Camouflaging vitiligo with dihydroxyacetone","volume":"14","author":"Hsu","year":"2008","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2010.10.043_bib173","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/j.1365-4632.2008.03356.x","article-title":"Dihydroxyacetone: a safe camouflaging option in vitiligo","volume":"47","author":"Rajatanavin","year":"2008","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib174","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1159\/000051757","article-title":"Dihydroxyacetone in a new formulation\u2014a powerful therapeutic option in vitiligo","volume":"203","author":"Fesq","year":"2001","journal-title":"Dermatology"},{"key":"10.1016\/j.jaad.2010.10.043_bib175","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1001\/archderm.144.6.809","article-title":"Camouflaging vitiligo of the fingers","volume":"144","author":"Tanioka","year":"2008","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib176","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1111\/j.1346-8138.2002.tb00210.x","article-title":"Evaluation of cosmetic tattooing in localised stable vitiligo","volume":"29","author":"Mahajan","year":"2002","journal-title":"J Dermatol"},{"issue":"pt 3","key":"10.1016\/j.jaad.2010.10.043_bib177","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1348\/000711299160077","article-title":"Coping with the disfiguring effects of vitiligo: a preliminary investigation into the effects of cognitive-behavioural therapy","volume":"72","author":"Papadopoulos","year":"1999","journal-title":"Br J Med Psychol"},{"key":"10.1016\/j.jaad.2010.10.043_bib178","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1111\/j.1365-4632.2006.02744.x","article-title":"Increased tumor necrosis factor alpha (TNF-alpha) and interleukin 1 alpha (IL1-alpha) levels in the lesional skin of patients with nonsegmental vitiligo","volume":"45","author":"Birol","year":"2006","journal-title":"Int J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib179","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1159\/000112932","article-title":"Vitiligo improvement in a patient with ankylosing spondylitis treated with infliximab","volume":"216","author":"Simon","year":"2008","journal-title":"Dermatology"},{"issue":"2\u00a0suppl. 1","key":"10.1016\/j.jaad.2010.10.043_bib180","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/j.jaad.2008.03.032","article-title":"Repigmentation of vitiligo during efalizumab","volume":"59","author":"Wakkee","year":"2008","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib181","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2310\/7750.2008.08023","article-title":"Familial coexisting and colocalized psoriasis and vitiligo responding to alefacept","volume":"13","author":"Al-Mutairi","year":"2009","journal-title":"J Cutan Med Surg"},{"key":"10.1016\/j.jaad.2010.10.043_bib182","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1529-8019.2010.01328.x","article-title":"Oral minocycline in the treatment of vitiligo\u2014a preliminary study","volume":"23","author":"Parsad","year":"2010","journal-title":"Dermatol Ther"},{"key":"10.1016\/j.jaad.2010.10.043_bib183","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/09546630600791442","article-title":"The efficacy of combined PUVA and low-dose azathioprine for early and enhanced repigmentation in vitiligo patients","volume":"17","author":"Radmanesh","year":"2006","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/j.jaad.2010.10.043_bib184","first-page":"30","article-title":"Repigmentation in vitiligo universalis: role of melanocyte density, disease duration, and melanocytic reservoir","volume":"11","author":"Dogra","year":"2005","journal-title":"Dermatol Online J"},{"key":"10.1016\/j.jaad.2010.10.043_bib185","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/1523-1747.ep12470453","article-title":"Enhanced integumental and ocular amelanosis following the termination of cyclosporine administration","volume":"88","author":"Pardue","year":"1987","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib186","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/archderm.1990.01670270071012","article-title":"Oral cyclosporine in the treatment of inflammatory and noninflammatory dermatoses. A clinical and immunopathologic analysis","volume":"126","author":"Gupta","year":"1990","journal-title":"Arch Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib187","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1016\/S0190-9622(03)02095-4","article-title":"Treatment of vitiligo with limited resources in Bangladesh","volume":"49","author":"Hossain","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib188","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1111\/j.1365-2133.2005.06556.x","article-title":"A randomized placebo-controlled double-blind study of levamisole in the treatment of limited and slowly spreading vitiligo","volume":"153","author":"Agarwal","year":"2005","journal-title":"Br J Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib189","unstructured":"Epocrates Online Web site. Available from: https:\/\/online.epocrates.com\/home. Accessed June 1, 2011."},{"key":"10.1016\/j.jaad.2010.10.043_bib190","unstructured":"Drugstore Web site. Available from: www.drugstore.com. Accessed June 1, 2011."},{"key":"10.1016\/j.jaad.2010.10.043_bib191","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1016\/j.jaad.2003.09.028","article-title":"Cost analysis of narrowband UVB phototherapy in psoriasis","volume":"50","author":"Langan","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.jaad.2010.10.043_bib192","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1097\/01720610-200812000-00015","article-title":"Treating vitiligo and psoriasis with the excimer laser","volume":"21","author":"Grubb","year":"2008","journal-title":"JAAPA"},{"key":"10.1016\/j.jaad.2010.10.043_bib193","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/j.1600-0749.2006.00355.x","article-title":"The definition and assessment of vitiligo: a consensus report of the vitiligo european task force","volume":"20","author":"Taieb","year":"2007","journal-title":"Pigment Cell Res"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211000399?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962211000399?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T22:21:37Z","timestamp":1759270897000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962211000399"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":193,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,9]]}},"alternative-id":["S0190962211000399"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2010.10.043","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.714347802.789852805","asserted-by":"object"}]},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitiligo: A comprehensive overview","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2010.10.043","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2010 American Academy of Dermatology, Inc. Published by Mosby, Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}